"Carcinoma, Endometrioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
Descriptor ID |
D018269
|
MeSH Number(s) |
C04.557.470.200.025.240 C04.588.945.418.948.585.124 C13.351.500.056.630.705.331 C13.351.937.418.685.331 C13.351.937.418.875.200.124 C19.391.630.705.331
|
Concept/Terms |
Carcinoma, Endometrioid- Carcinoma, Endometrioid
- Carcinomas, Endometrioid
- Endometrioid Carcinoma
- Endometrioid Carcinomas
Adenocarcinoma, Endometrioid- Adenocarcinoma, Endometrioid
- Adenocarcinomas, Endometrioid
- Endometrioid Adenocarcinomas
- Endometrioid Adenocarcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Endometrioid".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Endometrioid [C04.557.470.200.025.240]
- Neoplasms by Site [C04.588]
- Urogenital Neoplasms [C04.588.945]
- Genital Neoplasms, Female [C04.588.945.418]
- Uterine Neoplasms [C04.588.945.418.948]
- Endometrial Neoplasms [C04.588.945.418.948.585]
- Carcinoma, Endometrioid [C04.588.945.418.948.585.124]
- Female Urogenital Diseases and Pregnancy Complications [C13]
- Female Urogenital Diseases [C13.351]
- Genital Diseases, Female [C13.351.500]
- Adnexal Diseases [C13.351.500.056]
- Ovarian Diseases [C13.351.500.056.630]
- Ovarian Neoplasms [C13.351.500.056.630.705]
- Carcinoma, Endometrioid [C13.351.500.056.630.705.331]
- Urogenital Neoplasms [C13.351.937]
- Genital Neoplasms, Female [C13.351.937.418]
- Ovarian Neoplasms [C13.351.937.418.685]
- Carcinoma, Endometrioid [C13.351.937.418.685.331]
- Uterine Neoplasms [C13.351.937.418.875]
- Endometrial Neoplasms [C13.351.937.418.875.200]
- Carcinoma, Endometrioid [C13.351.937.418.875.200.124]
- Endocrine System Diseases [C19]
- Gonadal Disorders [C19.391]
- Ovarian Diseases [C19.391.630]
- Ovarian Neoplasms [C19.391.630.705]
- Carcinoma, Endometrioid [C19.391.630.705.331]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Endometrioid".
This graph shows the total number of publications written about "Carcinoma, Endometrioid" by people in this website by year, and whether "Carcinoma, Endometrioid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2012 | 2 | 0 | 2 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2015 | 2 | 1 | 3 |
2016 | 3 | 0 | 3 |
2017 | 7 | 2 | 9 |
2018 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Endometrioid" by people in Profiles.
-
Endometrial Cancer Characteristics and Risk of Recurrence. Am J Clin Pathol. 2022 Jan 06; 157(1):90-97.
-
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2022 02; 164(2):398-405.
-
Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion. Int J Gynecol Cancer. 2020 11; 30(11):1738-1747.
-
The Reliability of Intraoperative Assessment on Predicting Tumor Size, Myometrial Invasion, and Cervical Involvement in Patients With a Preoperative Diagnosis of Complex Atypical Hyperplasia or (Clinical Stage I) Endometrial Cancer: A Prospective Cohort Study. Am J Clin Oncol. 2020 02; 43(2):122-127.
-
Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? Gynecol Oncol. 2020 03; 156(3):568-574.
-
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103.
-
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N Engl J Med. 2018 12 27; 379(26):2495-2505.
-
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11.
-
Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 12; 147(3):648-653.
-
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. 2017 Oct 15; 123(20):4004-4012.